Second MEK Inhibitor Shows Promise in Neurofibromatosis Type 1 With Symptomatic Plexiform Neurofibromas Signaling Hope for Other RASopathies. - Cook SJ (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)